19 results match your criteria: "Center for Endocrine and Metabolic Disorders[Affiliation]"
Exp Clin Endocrinol Diabetes
November 2020
Center for Endocrine and Metabolic Disorders, Reproductive and Prenatal Medicine, Endokrinologikum Hamburg Betriebsgesellschaft mbH, Hamburg, Germany.
Exp Clin Endocrinol Diabetes
November 2020
Center for Endocrine and Metabolic Disorders, Reproductive and Prenatal Medicine, Endokrinologikum Hamburg Betriebsgesellschaft mbH, Hamburg, Germany.
Background: Subacute thyroiditis (SAT) is a rare inflammatory disease that presents diagnostic challenges. The underlying pathophysiology and prediction of outcomes are elusive. We investigated the long-term follow-up of SAT for up to 30 years and determined predictors for later hypothyroidism.
View Article and Find Full Text PDFClin Auton Res
February 2019
Strelitz Diabetes Center for Endocrine and Metabolic Disorders and Neuroendocrine Unit, Department of Medicine, Eastern Virginia Medical School, Norfolk, VA, USA.
PLoS One
July 2017
Strelitz Diabetes Center for Endocrine and Metabolic Disorders and the Neuroendocrine Unit, Department of Medicine; Eastern Virginia Medical School, Norfolk, Virginia, United States of America.
Objective: The aim was to evaluate the impact of bariatric surgery on cardiac and sudomotor autonomic C-fiber function in obese subjects with and without Type 2 diabetes mellitus (T2DM), using sudorimetry and heart rate variability (HRV) analysis.
Method: Patients were evaluated at baseline, 4, 12 and 24 weeks after vertical sleeve gastrectomy or Roux-en-Y gastric bypass. All subjects were assessed using SudoscanTM to measure electrochemical skin conductance (ESC) of hands and feet, time and frequency domain analysis of HRV, Neurologic Impairment Scores of lower legs (NIS-LL), quantitative sensory tests (QST) and sural nerve conduction studies.
Diabetes Technol Ther
June 2016
10 Clinical Physiology and Exercise Service, VISAS Centre, CHU Saint Etienne , Saint Etienne, France .
Background: Sudomotor dysfunction is one of the earliest pathophysiologic abnormalities in diabetes. Sudoscan™ (Impeto Medical, Paris, France) was developed as a noninvasive, rapid, and quantitative assessment of sudomotor function and has been shown to be sensitive in the detection of neuropathy. This global collaborative analysis aimed to establish reference values in healthy subjects of different ethnic groups, age, and gender, to define factors potentially affecting results, and to provide standardization of the methodology.
View Article and Find Full Text PDFClin J Am Soc Nephrol
July 2015
Strelitz Diabetes Center for Endocrine and Metabolic Disorders and the Neuroendocrine Unit, Department of Medicine, Eastern Virginia Medical School, Norfolk, Virginia
J Diabetes Sci Technol
May 2015
Eastern Virginia Medical School, Department of Medicine, Strelitz Diabetes Center for Endocrine and Metabolic Disorders, Norfolk, VA, USA
Background: This study explores the relationship between education for inpatient diabetes providers and the utilization of insulin order sets, inpatient glucometrics, and length of stay in a large health care system.
Methods: The study included patients with and without the diagnosis of diabetes. An education campaign included provider-directed diabetes education administered via online learning modules and in-person presentations by trained individuals.
Handb Clin Neurol
July 2016
Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia.
Diabetic distal symmetric sensorimotor polyneuropathy (DSPN) represents a major health problem, associated with excruciating neuropathic pain, increased morbidity and impaired quality of life. The understanding of its epidemiology is difficult due to methodological issues. Inconsistency in the selection of diagnostic procedures renders comparison between studies problematic.
View Article and Find Full Text PDFDiabetes Technol Ther
November 2013
Strelitz Diabetes Center for Endocrine and Metabolic Disorders and the Neuroendocrine Unit , Department of Medicine, Eastern Virginia Medical School.
Objective: Sudomotor dysfunction may be an early detectable abnormality in diabetic small fiber neuropathy. The aim of this study was to evaluate the efficacy of Sudoscan™ (Impeto Medical, Paris, France) in detecting diabetic neuropathy (DN), in comparison with other standardized tests, in patients with diabetes mellitus (DM).
Subjects And Methods: Sudoscan measures electrochemical skin conductance (ESC) of hands and feet through reverse iontophoresis.
Curr Diab Rep
August 2013
Strelitz Diabetes Center for Endocrine and Metabolic Disorders, Eastern Virginia Medical School, Norfolk, VA 23510, USA.
In this review of thermoregulatory function in health and disease, we review the basic mechanisms controlling skin blood flow of the hairy and glabrous skin and illustrate the major differences in blood flow to glabrous skin, which is, in essence, sympathetically mediated, while hairy skin is dependent upon neuropeptidergic signals, nitric oxide, and prostaglandin, among others. Laser Doppler methods of quantification of blood flow--in response to iontophoresis of acetylcholine or heat--and nociceptor-mediated blood flow have relatively uniformly demonstrated an impaired capacity to increase blood flow to the skin in diabetes and in its forerunners, prediabetes and the metabolic syndrome. This reduced capacity is likely to be a significant contributor to the development of foot ulcerations and amputations in diabetes, and means of increasing blood flow are clearly needed.
View Article and Find Full Text PDFDiabetes Metab Syndr Obes
March 2013
Strelitz Diabetes Center for Endocrine and Metabolic Disorders, Eastern Virginia Medical School, Norfolk, VA, USA.
Diabetic peripheral neuropathy is a common complication of diabetes. It presents as a variety of syndromes for which there is no universally accepted unique classification. Sensorimotor polyneuropathy is the most common type, affecting about 30% of diabetic patients in hospital care and 25% of those in the community.
View Article and Find Full Text PDFDiabetes Technol Ther
February 2013
Strelitz Diabetes Center for Endocrine and Metabolic Disorders, Department of Medicine, Eastern Virginia Medical School, Norfolk, Virginia 23510, USA.
Background: Small fiber peripheral neuropathy (SFN) is emerging as a common complication in diabetes. Currently there are few, not easily available methods of determining the integrity of small nerve fibers. This study was designed to determine the utility of a noninvasive technique, contact heat-evoked potential stimulation (CHEPS), on the identification of SFN and compare it with standardized measures of diabetic peripheral neuropathy (DPN).
View Article and Find Full Text PDFPain
March 2013
Department of Neuroscience, University of Turin Medical School, Turin 10125, Italy National Institute of Neuroscience Laboratories, Plateau Rosà Research Station, Breuil-Cervinia 11021, Italy Center for Endocrine and Metabolic Disorders, Aoste 11100, Italy.
Pain is a negative emotional experience that is modulated by a variety of psychological factors through different inhibitory systems. For example, endogenous opioids and cannabinoids have been found to be involved in stress and placebo analgesia. Here we show that when the meaning of the pain experience is changed from negative to positive through verbal suggestions, the opioid and cannabinoid systems are co-activated and these, in turn, increase pain tolerance.
View Article and Find Full Text PDFJ Diabetes
March 2013
Division of Endocrinology and Metabolism, Department of Medicine, Strelitz Diabetes Center for Endocrine and Metabolic Disorders, Eastern Virginia Medical School, Norfolk, VA, USA.
Background: Although niacin often has beneficial effects on the lipoprotein profile, flushing is an untoward effect associated with its use. Aspirin can only reduce the flushing response by 30-40%. Thus, the aim of the present study was to investigate the mechanisms of niacin-induced flushing, with and without aspirin, in normal, healthy individuals.
View Article and Find Full Text PDFExp Diabetes Res
March 2012
Division of Endocrinology and Metabolism, Department of Medicine, Eastern Virginia Medical School, Strelitz Diabetes Center for Endocrine and Metabolic Disorders, 855 West Brambleton Avenue, Norfolk, VA 23510, USA.
Introduction: Diabetics die from cardiovascular disease at a much greater rate than nondiabetics. Cardiac autonomic imbalance predicts increased cardiovascular risk and mortality. We studied the relationship between cardiac autonomic imbalance and adipose tissue-derived inflammation in newly diagnosed and established type 2 diabetes.
View Article and Find Full Text PDFEndocrinol Metab Clin North Am
March 2011
Neuroendocrine Unit, Strelitz Diabetes Center for Endocrine and Metabolic Disorders, Eastern Virginia Medical School, 855 West Brambleton Avenue, Norfolk, VA 23510, USA.
The measurement of health-related quality of life (HRQOL) has become essential for evaluating the impact of neuroendocrine tumors (NETs) on symptoms and social, emotional, psychological, and physical functioning of patients who harbor these tumors. This article describes instruments that have been developed to capture the spectrum of symptoms and the impact of the disease on their overall well-being. The authors discuss the importance of adequate sensitivity, specificity, and reproducibility and the value of psychometric factor analysis to explore the domains that embrace the manifestations of these tumors as well as aspects of the instruments that reflect tumor burden, biochemical, and hormonal status.
View Article and Find Full Text PDFPancreas
August 2010
Research and Neuroendocrine Unit, Eastern Virginia Medical School Strelitz Diabetes Center for Endocrine and Metabolic Disorders, Norfolk, VA 23510, USA.
Objectives: This supplement represents the proceedings of a panel of investigators whose goal was to assess the quality of evidence pertaining to current therapeutic approaches in the management of neuroendocrine tumors (NETs). It will examine the differences in opinions between expert faculty and community physicians.
Methods: The Neuroendocrine Tumors Summit convened in December 2009 to address 6 statements prepared by panel members that reflect important questions in the management of NETs.
Pancreas
August 2010
Eastern Virginia Medical School, Strelitz Diabetes Center for Endocrine and Metabolic Disorders, Norfolk, VA 3510, USA.
Curr Diab Rep
April 2010
Department of Medicine, Strelitz Diabetes Center for Endocrine and Metabolic Disorders, Norfolk, VA 23510, USA.
Diabetic patients are at increased risk for developing cardiovascular disease, and they constitute a large proportion of the global cardiovascular disease burden. Although multiple drugs exist for treating the hyperglycemia associated with diabetes, few have been shown to reduce cardiovascular risk. Great hope surrounded the arrival of the thiazolidinediones-drugs that favorably affect insulin sensitivity, inflammation, and some aspects of lipid profiles in diabetic patients.
View Article and Find Full Text PDF